prof. dr hab. Mariusz Papp

prof. dr hab. Mariusz Papp

+48 12 6623352
pokój 24
Zakład Farmakologii

Dokonania naukowe

  • Publikacje

Dopamine D1 and D2 receptors in chronic mild stress: Analysis of dynamic receptor changes in an animal model of depression using in situ hybridization and autoradiography

Autorzy: Zurawek, D., Faron-Górecka, A., Kuśmider, M., Solich, J., Kolasa, M., Szafran-Pilch, K., Kmiotek, K., Gruca, P., Papp, M., Dziedzicka-Wasylewska, M.

DOI: 10.1007/978-1-4939-2196-6_20
Date: 2014-01-01

Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits.

Autorzy: Pochwat B, Szewczyk B, Sowa-Kucma M, Siwek A, Doboszewska U, Piekoszewski W, Gruca P, Papp M, Nowak G

DOI: 10.1017/s1461145713001089
Date: 2013-09-01

The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu₂/₃ receptor agonist, LY379268, is 5-HT₁A dependent.

Autorzy: Wierońska JM, Sławińska A, Stachowicz K, Łasoń-Tyburkiewicz M, Gruca P, Papp M, Pilc A

DOI: 10.1016/j.bbr.2013.08.007
Date: 2013-08-01

The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents.

Autorzy: Sławińska A, Wierońska JM, Stachowicz K, Marciniak M, Lasoń-Tyburkiewicz M, Gruca P, Papp M, Kusek M, Tokarski K, Doller D, Pilc A

DOI: 10.1111/bph.12254
Date: 2013-08-01

The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling.

Autorzy: Wierońska JM, Acher FC, Sławińska A, Gruca P, Lasoń-Tyburkiewicz M, Papp M, Pilc A

DOI: 10.1007/s00213-013-3005-0
Date: 2013-03-01

Mesolimbic dopamine D₂ receptor plasticity contributes to stress resilience in rats subjected to chronic mild stress.

Autorzy: Zurawek D, Faron-Górecka A, Kuśmider M, Kolasa M, Gruca P, Papp M, Dziedzicka-Wasylewska M

DOI: 10.1007/s00213-013-2990-3
Date: 2013-02-01

Models of affective illness: chronic mild stress in the rat.

Autorzy: Papp M

DOI: 10.1002/0471141755.ph0509s57
Date: 2012-06-01

Long-lasting increase in [³H]CP55,940 binding to CB1 receptors following cocaine self-administration and its withdrawal in rats.

Autorzy: Adamczyk P, Faron-Górecka A, Kuśmider M, Dziedzicka-Wasylewska M, Papp M, Filip M

DOI: 10.1016/j.brainres.2012.02.052
Date: 2012-02-01

S32212, a novel serotonin type 2C receptor inverse agonist/α <sub>2</sub>- adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization

Autorzy: Dekeyne, A., Brocco, M., Loiseau, F., Gobert, A., Rivet, J.-M., Di Cara, B., Cremers, T.I., Flik, G., Fone, K.C.F., Watson, D.J.G., Papp, M., Sharp, T., Serres, F., Cespuglio, R., Olivier, B., Chan, J.S.W., Lavielle, G., Millan, M.J.

DOI: 10.1124/jpet.111.187534
Date: 2012-01-01

The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.

Autorzy: Adamczyk P, Miszkiel J, McCreary AC, Filip M, Papp M, Przegaliński E

DOI: 10.1016/j.brainres.2012.01.030
Date: 2012-01-01

Zobacz także